医学
全身照射
造血干细胞移植
移植
肿瘤科
内科学
干细胞
人口
化疗
环磷酰胺
遗传学
生物
环境卫生
作者
Janak Adhikari,Priyadarshani Sharma,Vijaya Raj Bhatt
出处
期刊:Future Oncology
[Future Medicine]
日期:2015-12-01
卷期号:11 (23): 3175-3185
被引量:22
摘要
The risk of secondary solid malignancies is increased after allogeneic hematopoietic stem cell transplantation (HSCT). The risk starts at about 10 years after HSCT and continues even 20 years later. The most common secondary malignancies include squamous cell carcinoma of skin, genitourinary tract and oral cavity; lung and breast cancers. The use of total body irradiation or conditioning chemotherapy, chronic graft-versus-host disease and duration since HSCT can influence the risk of secondary solid malignancies. Secondary solid malignancies are common causes of nonrelapse mortality in long-term survivors and may account for up to 10% of late deaths. Avoiding smoking, alcohol use and excess sun exposure may reduce the risk. Cancer prevention guidelines are largely consensus-driven and follow the recommendations for general population.
科研通智能强力驱动
Strongly Powered by AbleSci AI